Navigation Links
New research initiative investigates gene regulation in evolution and development
Date:4/2/2014

Johannes Gutenberg University Mainz (JGU) has received EUR 900,000 for three years to investigate, jointly with the Institute of Molecular Biology (IMB), how gene regulation affects evolution and development. The ambitious new research initiative GeneRED, or Gene Regulation in Evolution and Development, is jointly run by IMB and JGU's Faculty of Biology, funded by the Ministry of Education, Science, Continuing Education, and Culture of Rhineland-Palatinate. Its overarching goal is to gain insight into how epigenetics, i.e., the regulation of genes by elements outside the classical DNA code, can influence the development of organisms, both in the short term (growth and aging) and the long term (evolutionary adaptation).

The initiative aims to significantly strengthen research into gene regulation on the campus of Johannes Gutenberg University Mainz. To achieve this, it will fund six PhD positions at JGU's Faculty of Biology over three years (2014-2016). The questions these students are studying are:

  • How did division of labor evolve in social insects like ants, and which genes are involved?
  • How does the NURF complex help maintain neural stem cell identity in fruit flies?
  • What are the targets of the NG2 protein in glial cell development and tumors?
  • How do ciliary proteins affect DNA damage response and gene regulation in Usher syndrome?
  • What are the roles of genetic regulatory elements in the modern human adaptation to an agriculturalist diet and predisposition to metabolic syndrome?
  • Which epigenetic factors are involved in creating body size memory in fruit flies?

The participating PhD students will be fully integrated into the International PhD Program on "Dynamics of Gene Regulation, Epigenetics and DNA Damage Response," a joint program coordinated by IMB with groups from IMB, JGU, the Mainz University Medical Center, and the Max Planck Institute for Polymer Research.

The initiative will also help expand access to modern proteomics technologies for scientists at JGU and IMB. With proteomics becoming a key methodology in modern biomedical research, the support provided through this initiative will be crucial in ensuring that research in Mainz is internationally competitive.

The chairs of the GeneRED project are Hans Zischler, Dean of the Faculty of Biology at JGU, and Christof Niehrs, Founding and Executive Director of IMB. The General Manager of GeneRED is Ralf Dahm, IMB's Director of Scientific Management.


'/>"/>

Contact: Dr. Ralf Dahm
press@imb-mainz.de
49-613-139-21450
Johannes Gutenberg Universitaet Mainz
Source:Eurekalert

Related biology news :

1. Research method integrates meditation, science
2. Global research possibilities expand as IISD assumes operation of Canadas famed Experimental Lakes
3. UCLA scientist awarded $3 million to fund research into proteins affecting the kidney
4. Cfaed starts a research project on organic electronics with the University of Brasília
5. Researchers reveal a new pathway through the sodium pump
6. Researchers uncover secrets of a mollusks unique bioceramic armor
7. Scripps Florida scientists offer best practices nutrition measurement for researchers
8. Researchers identify new protein markers that may improve understanding of heart disease
9. Research clarifies health costs of air pollution from agriculture
10. Two researchers known for identifying and treating bubble boy disease honored by March of Dimes
11. Research center to develop next generation of advanced chemical products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... , April 28, 2016 First quarter ... (139.9), up 966% compared with the first quarter of 2015 ... totaled SEK 589.1 M (loss: 18.8) and the operating margin was ... (loss: 0.32) Cash flow from operations was SEK 249.9 ... 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. The ...
(Date:4/15/2016)... 15, 2016  A new partnership announced today ... underwriting decisions in a fraction of the time ... and high-value life insurance policies to consumers without ... With Force Diagnostics, rapid testing (A1C, Cotinine and ... (blood pressure, weight, pulse, BMI, and activity data) ...
(Date:3/31/2016)... 31, 2016   ... the "Company") LegacyXChange is excited to release ... soon to be launched online site for trading 100% ... ) will also provide potential shareholders a sense of ... to an industry that is notorious for fraud. The ...
Breaking Biology News(10 mins):
(Date:5/20/2016)... ... May 20, 2016 , ... Korean researchers say Manumycin A ... offer a new way to treat the disease. Surviving Mesothelioma has just posted an ... Scientists from several Korean institutions based their mesothelioma study on the fact the Manumycin ...
(Date:5/19/2016)... , ... May 19, 2016 , ... Anton Paar USA, ... square foot office building is complete. The new structure adds a third office building ... Anton Paar USA purchased 2.4 acres of land, along with office space adjacent ...
(Date:5/19/2016)... NEW YORK , May 19, 2016 ... Biotech space will fully recover given the relentless pressures ... is for sure in the investors circle though - ... requires due-diligence. Ahead of today,s session, ActiveWallSt.com,s presents four ... PTLA ), Vitae Pharmaceuticals Inc. (NASDAQ: ...
(Date:5/19/2016)... , May 19, 2016 ... and (OTC PINK: RGBPP) announced today initiation of ... first cord blood based cancer immunotherapeutic product leveraging ... application, Regen described a generation of cord blood ... by gene silencing.  The product in development will ...
Breaking Biology Technology: